Stock listing
NASDAQ:GDTC CytoMed Therapeutics Limited Stock
Home listing (NASDAQ) of CytoMed Therapeutics Limited
Follow CytoMed Therapeutics Limited into a list and get an email when it puts out news.
Share price · NASDAQ:GDTC
$0.859 USD -0.021 (-2.4%)
Close on Nov 6, 2026
- Day range
- $0.800 – $0.870 USDNov 6, 2026
- Volume
- 8,887 sharesNov 6, 2026
- Market cap
- $10.25M USDAt the close on Nov 6, 2026 · price × 11.93M shares outstanding
- 52-week range
- $0.680 – $2.290 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $16,767 USDMedian day 11,931 shares · 2 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GDTC · Home | $0.859 USD | -0.021 (-2.4%) | 8,887 | $0.850 | $0.870 | $0.800 | $0.880 | Close on Nov 6, 2026 |
| Frankfurt:F98 | €0.715 EUR | -0.055 (-7.1%) | — | €0.750 | €0.750 | €0.715 | €0.770 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:GDTC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.859 | -0.021 | -2.4% | $0.850 | $0.870 | $0.800 | 8,887 | |
| $0.880 | -0.009 | -1.0% | $0.812 | $0.890 | $0.812 | 5,063 | |
| $0.889 | -0.021 | -2.3% | $0.831 | $0.892 | $0.831 | 6,383 | |
| $0.910 | +0.000 | 0.0% | $0.920 | $0.920 | $0.852 | 5,178 | |
| $0.910 | -0.009 | -1.0% | $0.911 | $0.920 | $0.855 | 47,321 | |
| $0.919 | +0.018 | +2.0% | $0.830 | $0.919 | $0.829 | 11,444 | |
| $0.901 | -0.034 | -3.7% | $0.863 | $0.930 | $0.850 | 11,962 | |
| $0.935 | +0.045 | +5.1% | $0.820 | $0.935 | $0.820 | 10,118 | |
| $0.890 | -0.036 | -3.9% | $0.890 | $0.893 | $0.850 | 16,965 | |
| $0.926 | +0.007 | +0.8% | $0.900 | $0.940 | $0.845 | 12,490 | |
| $0.919 | 0.000 | 0.0% | $0.840 | $0.919 | $0.840 | 4,300 | |
| $0.919 | 0.000 | 0.0% | $0.875 | $0.919 | $0.822 | 5,900 | |
| $0.919 | +0.047 | +5.4% | $0.811 | $0.919 | $0.811 | 5,000 | |
| $0.872 | +0.020 | +2.3% | $0.820 | $0.872 | $0.812 | 8,300 | |
| $0.852 | -0.028 | -3.2% | $0.850 | $0.865 | $0.842 | 15,000 | |
| $0.880 | +0.010 | +1.1% | $0.940 | $0.940 | $0.840 | 7,300 | |
| $0.870 | +0.010 | +1.2% | $0.806 | $0.880 | $0.730 | 9,500 | |
| $0.860 | -0.010 | -1.1% | $0.830 | $0.866 | $0.810 | 10,600 | |
| $0.870 | +0.059 | +7.3% | $0.865 | $0.880 | $0.811 | 24,000 | |
| $0.811 | -0.079 | -8.9% | $0.841 | $0.983 | $0.710 | 54,800 | |
| $0.890 | -0.055 | -5.8% | $0.939 | $0.940 | $0.853 | 11,800 | |
| $0.945 | -0.035 | -3.6% | $0.900 | $0.945 | $0.900 | 23,200 | |
| $0.980 | +0.050 | +5.4% | $0.900 | $0.980 | $0.800 | 15,200 | |
| $0.930 | -0.080 | -7.9% | $0.950 | $0.950 | $0.865 | 18,600 | |
| $1.010 | +0.090 | +9.8% | $0.845 | $1.060 | $0.845 | 63,800 | |
| $0.920 | +0.020 | +2.2% | $0.800 | $0.920 | $0.770 | 33,700 | |
| $0.900 | +0.057 | +6.8% | $0.843 | $0.900 | $0.838 | 6,400 | |
| $0.843 | -0.046 | -5.2% | $0.816 | $0.850 | $0.770 | 13,000 | |
| $0.889 | -0.036 | -3.9% | $0.851 | $0.891 | $0.810 | 25,400 | |
| $0.925 | -0.030 | -3.1% | $0.899 | $0.930 | $0.849 | 6,500 | |
| $0.955 | +0.045 | +4.9% | $0.910 | $0.955 | $0.880 | 11,800 | |
| $0.910 | 0.000 | 0.0% | $0.910 | $0.910 | $0.856 | 5,400 | |
| $0.910 | 0.000 | 0.0% | $0.876 | $0.910 | $0.874 | 9,700 | |
| $0.910 | -0.060 | -6.2% | $0.950 | $0.950 | $0.870 | 32,300 | |
| $0.970 | -0.010 | -1.0% | $0.970 | $0.970 | $0.812 | 33,400 | |
| $0.980 | +0.094 | +10.6% | $0.820 | $0.980 | $0.766 | 20,700 | |
| $0.886 | 0.000 | 0.0% | $0.842 | $0.886 | $0.795 | 7,400 | |
| $0.886 | +0.081 | +10.1% | $0.863 | $0.886 | $0.806 | 4,300 | |
| $0.805 | -0.047 | -5.5% | $0.852 | $0.852 | $0.800 | 19,900 | |
| $0.852 | +0.070 | +9.0% | $0.770 | $0.900 | $0.770 | 12,500 | |
| $0.782 | -0.028 | -3.5% | $0.838 | $0.838 | $0.774 | 10,000 | |
| $0.810 | +0.015 | +1.9% | $0.850 | $0.850 | $0.800 | 9,100 | |
| $0.795 | -0.075 | -8.6% | $0.853 | $0.930 | $0.790 | 24,300 | |
| $0.870 | +0.009 | +1.0% | $0.861 | $0.873 | $0.823 | 3,900 | |
| $0.861 | -0.019 | -2.2% | $0.930 | $0.930 | $0.850 | 16,600 | |
| $0.880 | 0.000 | 0.0% | $0.880 | $0.880 | $0.880 | 0 | |
| $0.880 | -0.029 | -3.2% | $0.851 | $0.900 | $0.850 | 12,900 | |
| $0.909 | 0.000 | 0.0% | $0.909 | $0.909 | $0.909 | 0 | |
| $0.909 | -0.011 | -1.2% | $0.919 | $0.919 | $0.762 | 11,900 | |
| $0.920 | -0.030 | -3.2% | $0.901 | $0.920 | $0.860 | 2,500 | |
| $0.950 | -0.047 | -4.7% | $0.980 | $0.988 | $0.950 | 18,900 | |
| $0.997 | +0.062 | +6.6% | $0.935 | $0.997 | $0.910 | 2,800 | |
| $0.935 | -0.065 | -6.5% | $1.000 | $1.000 | $0.920 | 28,056 | |
| $1.000 | -0.030 | -2.9% | $1.000 | $1.000 | $0.928 | 74,011 | |
| $1.030 | +0.131 | +14.6% | $0.803 | $1.030 | $0.803 | 54,700 | |
| $0.899 | -0.001 | -0.1% | $0.890 | $0.899 | $0.860 | 5,400 | |
| $0.900 | -0.040 | -4.3% | $0.980 | $0.980 | $0.890 | 16,700 | |
| $0.940 | +0.034 | +3.8% | $0.898 | $0.960 | $0.898 | 4,000 | |
| $0.906 | -0.043 | -4.5% | $0.912 | $0.980 | $0.880 | 24,500 | |
| $0.949 | +0.104 | +12.3% | $0.851 | $0.949 | $0.800 | 30,500 | |
| $0.845 | +0.036 | +4.4% | $0.800 | $0.845 | $0.800 | 27,800 | |
| $0.809 | -0.034 | -4.0% | $0.843 | $0.859 | $0.777 | 14,700 | |
| $0.843 | +0.043 | +5.3% | $0.810 | $0.843 | $0.800 | 2,744 | |
| $0.800 | -0.021 | -2.5% | $0.820 | $0.893 | $0.800 | 50,497 | |
| $0.821 | +0.018 | +2.2% | $0.875 | $0.875 | $0.821 | 3,800 | |
| $0.803 | -0.037 | -4.4% | $0.890 | $0.930 | $0.803 | 125,900 |
- Ticker
- NASDAQ:GDTC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 9, 2026
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Calls
Replays
CytoMed Therapeutics (NASDAQ:GDTC) Q2 2025 Earnings Call
Thu, Oct 02, 2025 · 10:00 AM ET
Watch Transcript
Latest news
CytoMed Therapeutics Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Oct 9, 2026
Closed $0.811 (-8.9%) on Oct 12, 2026
CytoMed Therapeutics: Audited Financial Statements for FY2025
May 6, 2026
Closed $0.92 (0.0%) on May 6, 2026
CytoMed Therapeutics Refutes Misleading Claims and Reaffirms Clinical Progress
Jan 28, 2026
Closed $0.825 (-1.3%) on Jan 28, 2026
CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital
Jan 13, 2026
Closed $1.22 (-1.6%) on Jan 13, 2026
CytoMed Therapeutics Announces Novel First-In-Human Clinical Trial Collaborations with Renowned and Prestigious Hospital Partner to Advance Its Off-The-Shelf Donor-Derived Gamma Delta T Cells Allogeneic Technology to Treat Cancers in Malaysia
Dec 8, 2025
Closed $1.85 (+4.5%) on Dec 8, 2025
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
Nov 18, 2025
Closed $1.97 (-0.5%) on Nov 18, 2025
Financings
Strategic investment of 10.0% post-money stake in subsidiary LongevityBank
Nov 6, 2025
Announced: up to US$500,000
Buyers: ICH Capital Pte Ltd (up to US$500,000 for a 10.0% post-money stake in LongevityBank)
At-the-market programme of ordinary shares
Aug 19, 2025
Announced: up to US$4.3M · R.F. Lafferty & Co., Inc.
Dealers: R.F. Lafferty & Co., Inc. (lead)
Use of proceeds: General corporate purposes, possibly including business diversification and development initiatives and capital expenditures
Decks
Investor Presentation (May 2023)
Investor deck · 24 slides · May 2023
CytoMed Therapeutics Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 6 in the last 12 months · 39 in all · newest Oct 9, 2026 · oldest 2023
- Calls
- 1 call with a replay · 1 with a transcript · latest Oct 2, 2025
- Decks
- 1 deck · latest May 2023
Where CytoMed Therapeutics Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GDTC · Home listing · This page | NASDAQ | United States | USD |
| BOATS:GDTC | BOATS | United States | USD |
| Frankfurt:F98 | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about CytoMed Therapeutics Limited.